Krönke, J
Kuchenbauer, F
Kull, M
Teleanu, V
Bullinger, L
Bunjes, D
Greiner, A
Kolmus, S
Köpff, S
Schreder, M
Mügge, L-O
Straka, C
Engelhardt, M
Döhner, H
Einsele, H
Bassermann, F
Bargou, R
Knop, S
Langer, C
Article History
Received: 17 August 2016
Revised: 4 November 2016
Accepted: 30 November 2016
First Online: 26 December 2016
Competing interests
: Celgene cooperation provided lenalidomide as study medication used in this trial. JK received honoraria from Celgene. SK received honoraria from Celgene, Amgen, Bristol-Myers Squibb, Janssen, Onyx. CL received honoraria from Celgene, Amgen, Bristol-Myers Squibb, Janssen, Novartis, Takeda Oncology.